Published in J Am Coll Cardiol on June 07, 2005
Myocardial Oedema in Acute Myocardial Infarction (AMI) | NCT00987259
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson (2009) 3.90
Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 2.34
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Advances in parametric mapping with CMR imaging. JACC Cardiovasc Imaging (2013) 2.02
Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging (2008) 1.91
T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson (2011) 1.79
Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging (2011) 1.75
Non-invasive imaging in the diagnosis of acute viral myocarditis. Clin Res Cardiol (2009) 1.66
Acute viral myocarditis. Eur Heart J (2008) 1.65
Cardiovascular magnetic resonance T2 signal abnormalities in left ventricular ballooning syndrome. Int J Cardiovasc Imaging (2009) 1.60
Myocardial edema--a new clinical entity? Nat Rev Cardiol (2010) 1.59
Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson (2013) 1.40
T2-weighted imaging to assess post-infarct myocardium at risk. JACC Cardiovasc Imaging (2011) 1.40
The role of cardiovascular magnetic resonance in pediatric congenital heart disease. J Cardiovasc Magn Reson (2011) 1.34
Value of MRI in patients with a clinical suspicion of acute myocarditis. Eur Radiol (2007) 1.26
Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson (2014) 1.26
Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson (2013) 1.21
Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios. Circulation (2008) 1.21
Inflammation in takotsubo cardiomyopathy: insights from cardiovascular magnetic resonance imaging. Eur Radiol (2009) 1.20
Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies. J Cardiovasc Magn Reson (2012) 1.17
CMR quantification of myocardial scar provides additive prognostic information in nonischemic cardiomyopathy. JACC Cardiovasc Imaging (2013) 1.17
The importance of cardiac MRI as a diagnostic tool in viral myocarditis-induced cardiomyopathy. Neth Heart J (2009) 1.14
Toward cardiovascular MRI at 7 T: clinical needs, technical solutions and research promises. Eur Radiol (2010) 1.12
Cardiovascular magnetic resonance for the diagnosis of acute myocarditis: prospects for detecting myocardial inflammation. J Am Coll Cardiol (2005) 1.11
Advances in cardiac magnetic resonance imaging of congenital heart disease. Pediatr Radiol (2015) 1.09
Viral myocarditis-diagnosis, treatment options, and current controversies. Nat Rev Cardiol (2015) 1.09
Cardiac magnetic resonance in myocardial disease. Heart (2006) 1.08
Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev (2013) 1.07
Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: diagnostic accuracy of visual and semi-quantitative assessment. J Cardiovasc Magn Reson (2012) 1.05
Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis--a CMR study. J Cardiovasc Magn Reson (2008) 1.04
Cardiovascular magnetic resonance in the diagnosis of acute heart transplant rejection: a review. J Cardiovasc Magn Reson (2009) 1.02
Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Am J Cardiol (2012) 0.99
Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: current applications and future perspectives. Heart Fail Rev (2006) 0.97
Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2010) 0.97
Magnetic resonance imaging findings in acute myocarditis and correlation with immunohistological parameters. Eur Radiol (2010) 0.97
Clinical characteristics and role of early cardiac magnetic resonance imaging in patients with suspected ST-elevation myocardial infarction and normal coronary arteries. Int J Cardiovasc Imaging (2010) 0.97
Assessment of acute myocarditis by cardiovascular MR: diagnostic performance of shortened protocols. Int J Cardiovasc Imaging (2013) 0.97
The utility of cardiovascular magnetic resonance in constrictive pericardial disease. Cardiol Rev (2009) 0.96
Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson (2014) 0.94
Diagnosis of viral myocarditis by cardiac magnetic resonance and viral genome detection in peripheral blood. Int J Cardiovasc Imaging (2012) 0.94
Acute myocarditis in a rat model: late gadolinium enhancement with histopathological correlation. Eur Radiol (2009) 0.93
Cardiac involvement in Wegener's granulomatosis resistant to induction therapy. Eur Radiol (2011) 0.92
Improved quantitative myocardial T2 mapping: Impact of the fitting model. Magn Reson Med (2014) 0.91
Cardiovascular magnetic resonance techniques and findings in children with myocarditis: a multicenter retrospective study. J Cardiovasc Magn Reson (2015) 0.90
The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy. Heart Fail Rev (2011) 0.90
Myocardial inflammation in Duchenne Muscular Dystrophy as a precipitating factor for heart failure: a prospective study. BMC Neurol (2010) 0.90
Diagnosis of early myocarditis after respiratory or gastrointestinal tract viral infection: insights from cardiovascular magnetic resonance. Clin Res Cardiol (2010) 0.90
Emerging concepts for myocardial late gadolinium enhancement MRI. Curr Cardiol Rev (2013) 0.89
Prognostic impact of T2-weighted CMR imaging for cardiac amyloidosis. Eur Radiol (2011) 0.89
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur Heart J (2011) 0.89
T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis. Clin Res Cardiol (2016) 0.88
Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis. Eur Heart J Cardiovasc Imaging (2015) 0.87
Cardiac magnetic resonance imaging: an essential diagnostic aid in suspected myocardial re-infarction in a 40 year old woman. Clin Res Cardiol (2008) 0.87
MR delayed enhancement imaging findings in suspected acute myocarditis. Eur Radiol (2009) 0.87
Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance. Circ Cardiovasc Imaging (2014) 0.87
Acute perimyocarditis mimicking transmural myocardial infarction. Int Arch Med (2009) 0.87
The emerging clinical role of cardiovascular magnetic resonance imaging. Can J Cardiol (2010) 0.87
High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Heart Vessels (2012) 0.87
Diagnostic contribution of cardiac magnetic resonance in patients with acute coronary syndrome and culprit-free angiograms. Med Sci Monit (2015) 0.86
Role of cardiac magnetic resonance in the evaluation of dilated cardiomyopathy: diagnostic contribution and prognostic significance. ISRN Radiol (2014) 0.86
Multiple old myocardial scars and new onset of myocarditis in two young patients presenting with ventricular tachycardias and dilated cardiomyopathy. Clin Res Cardiol (2010) 0.86
Diagnostic value of CMR in young patients with clinically suspected acute myocarditis is determined by cardiac enzymes. Clin Res Cardiol (2014) 0.85
Distribution of late gadolinium enhancement in various types of cardiomyopathies: Significance in differential diagnosis, clinical features and prognosis. World J Cardiol (2014) 0.85
Early non-invasive diagnosis and treatment of acute eosinophilic myopericarditis by cardiac magnetic resonance. J Korean Med Sci (2011) 0.85
Myocardial Inflammation-Are We There Yet? Curr Cardiovasc Imaging Rep (2015) 0.85
Diagnosis and management of ischemic cardiomyopathy: Role of cardiovascular magnetic resonance imaging. World J Cardiol (2014) 0.84
Combined electrocardiography, coronary angiography and magnetic resonance imaging for the diagnosis of viral myocarditis: A case report. Exp Ther Med (2014) 0.84
Steady-state first-pass perfusion (SSFPP): a new approach to 3D first-pass myocardial perfusion imaging. Magn Reson Med (2013) 0.84
Advances in Cardiovascular MRI for Diagnostics: Applications in Coronary Artery Disease and Cardiomyopathies. Expert Opin Med Diagn (2009) 0.83
Accuracy of cardiovascular magnetic resonance in myocarditis: comparison of MR and histological findings in an animal model. J Cardiovasc Magn Reson (2010) 0.83
Utility of cardiac magnetic resonance in the evaluation of unselected patients with possible arrhythmogenic right ventricular cardiomyopathy. Clin Med Insights Cardiol (2012) 0.82
Clozapine-induced myocarditis: recognizing a potentially fatal adverse reaction. Tex Heart Inst J (2015) 0.82
Contrast-enhancement cardiac magnetic resonance imaging beyond the scope of viability. Neth Heart J (2011) 0.82
Staged cardiovascular magnetic resonance for differential diagnosis of troponin T positive patients with low likelihood for acute coronary syndrome. J Cardiovasc Magn Reson (2010) 0.82
Cardiac magnetic resonance imaging in dilated cardiomyopathy in adults--towards identification of myocardial inflammation. Eur Radiol (2010) 0.81
Myocardial tissue characterization in Chagas' heart disease by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2015) 0.81
Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management. Heart Fail Rev (2013) 0.80
Clinically manifested myocarditis in acute rheumatic fever. Arq Bras Cardiol (2014) 0.80
The emerging role of cardiovascular magnetic resonance in the evaluation of Kawasaki disease. Int J Cardiovasc Imaging (2013) 0.80
Myocarditis mimicking acute myocardial infarction. Neth Heart J (2015) 0.79
Role of imaging in the detection of reversible cardiomyopathy. J Cardiovasc Ultrasound (2013) 0.79
Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection. Eur J Heart Fail (2010) 0.79
Assessment of sub-clinical acute cellular rejection after heart transplantation: comparison of cardiac magnetic resonance imaging and endomyocardial biopsy. Eur Radiol (2014) 0.79
Impact of motion correction on reproducibility and spatial variability of quantitative myocardial T2 mapping. J Cardiovasc Magn Reson (2015) 0.79
Importance of Reference Muscle Selection in Quantitative Signal Intensity Analysis of T2-Weighted Images of Myocardial Edema Using a T2 Ratio Method. Biomed Res Int (2015) 0.79
[MRI in chronic myocarditis]. Z Kardiol (2005) 0.79
Early gadolinium enhancement in hypertrophic cardiomyopathy: a potential premature marker of myocardial damage. Int J Cardiovasc Imaging (2016) 0.78
Mapping myocarditis: still searching for the north star. JACC Cardiovasc Imaging (2014) 0.78
ST elevation without myocardial infarction. BMJ Case Rep (2014) 0.78
Comprehensive Cardiac Magnetic Resonance for Short-Term Follow-Up in Acute Myocarditis. J Am Heart Assoc (2016) 0.78
Unexpected myocarditis in thalassaemia major patient screened for iron load cardiomyopathy. BMJ Case Rep (2009) 0.78
Mapping tissue inhomogeneity in acute myocarditis: a novel analytical approach to quantitative myocardial edema imaging by T2-mapping. J Cardiovasc Magn Reson (2015) 0.78
Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure? Int J Cardiovasc Imaging (2007) 0.78
Role of cardiac MRI in nonischemic cardiomyopathies. Indian Heart J (2016) 0.78
Acute myocarditis triggering coronary spasm and mimicking acute myocardial infarction. World J Cardiol (2014) 0.78
The role of non-invasive imaging in patients with suspected acute coronary syndrome. Br J Radiol (2011) 0.78
Heart Failure in Chronic Myocarditis: A Role for microRNAs? Curr Genomics (2015) 0.78
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA (2007) 5.31
Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA (2011) 4.14
Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet (2004) 3.88
Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson (2013) 3.87
Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation (2004) 3.76
Optimization and validation of a fully-integrated pulse sequence for modified look-locker inversion-recovery (MOLLI) T1 mapping of the heart. J Magn Reson Imaging (2007) 3.76
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17
The salvaged area at risk in reperfused acute myocardial infarction as visualized by cardiovascular magnetic resonance. J Am Coll Cardiol (2008) 3.09
Edema as a very early marker for acute myocardial ischemia: a cardiovascular magnetic resonance study. J Am Coll Cardiol (2009) 2.90
Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials. Circulation (2004) 2.73
Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med (2007) 2.72
Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int (2009) 2.72
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol (2009) 2.71
Bicuspid aortic valve is associated with altered wall shear stress in the ascending aorta. Circ Cardiovasc Imaging (2012) 2.53
Non-contrast T1-mapping detects acute myocardial edema with high diagnostic accuracy: a comparison to T2-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 2.34
Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage. Circ Res (2007) 2.25
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. J Am Coll Cardiol (2009) 2.23
Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. JACC Cardiovasc Imaging (2011) 2.22
AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase. Circulation (2003) 2.15
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Mutations in the human muscle LIM protein gene in families with hypertrophic cardiomyopathy. Circulation (2003) 2.12
Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging (2009) 2.08
Growth retardation and altered autonomic control in mice lacking brain serotonin. Proc Natl Acad Sci U S A (2009) 2.01
T2-weighted cardiovascular magnetic resonance imaging. J Magn Reson Imaging (2007) 2.01
Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging (2008) 1.91
Protein kinase CK2 links extracellular growth factor signaling with the control of p27(Kip1) stability in the heart. Nat Med (2008) 1.91
Dysfunction of dysferlin-deficient hearts. J Mol Med (Berl) (2007) 1.89
Flow measurement by cardiovascular magnetic resonance: a multi-centre multi-vendor study of background phase offset errors that can compromise the accuracy of derived regurgitant or shunt flow measurements. J Cardiovasc Magn Reson (2010) 1.88
T1 mapping in patients with acute myocardial infarction. J Cardiovasc Magn Reson (2003) 1.88
An open-source software tool for the generation of relaxation time maps in magnetic resonance imaging. BMC Med Imaging (2010) 1.80
T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson (2011) 1.79
Saturation recovery single-shot acquisition (SASHA) for myocardial T(1) mapping. Magn Reson Med (2013) 1.69
Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur J Heart Fail (2008) 1.64
Hemodynamic and neurohumoral effects of selective endothelin A (ET(A)) receptor blockade in chronic heart failure: the Heart Failure ET(A) Receptor Blockade Trial (HEAT). Circulation (2002) 1.64
Noninvasive imaging in myocarditis. J Am Coll Cardiol (2006) 1.62
Requirement of nuclear factor-kappaB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo. Circulation (2005) 1.59
Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia. Ann Neurol (2003) 1.54
Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial. Clin Res Cardiol (2008) 1.53
Training and accreditation in cardiovascular magnetic resonance in Europe: a position statement of the working group on cardiovascular magnetic resonance of the European Society of Cardiology. Eur Heart J (2011) 1.53
Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders. Stem Cells Dev (2010) 1.50
Vitronectin concentrations predict risk in patients undergoing coronary stenting. Circ Cardiovasc Interv (2008) 1.44
Connective tissue growth factor overexpression in cardiomyocytes promotes cardiac hypertrophy and protection against pressure overload. PLoS One (2009) 1.43
Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol (2007) 1.41
Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications. J Cardiovasc Magn Reson (2013) 1.40
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease. Nat Genet (2008) 1.38
Is routine ultrasound guidance really necessary for closure of patent foramen ovale using the Amplatzer PFO occluder? Catheter Cardiovasc Interv (2009) 1.38
Estimation of high-resolution HLA-A, -B, -C, -DRB1 allele and haplotype frequencies based on 8862 German stem cell donors and implications for strategic donor registry planning. Hum Immunol (2009) 1.37
Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol Cell (2002) 1.36
A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail (2006) 1.36
Apoptosis repressor with caspase recruitment domain is required for cardioprotection in response to biomechanical and ischemic stress. Circulation (2006) 1.33
A gain-of-function TBX20 mutation causes congenital atrial septal defects, patent foramen ovale and cardiac valve defects. J Med Genet (2009) 1.32
Imaging in population science: cardiovascular magnetic resonance in 100,000 participants of UK Biobank - rationale, challenges and approaches. J Cardiovasc Magn Reson (2013) 1.31
Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging (2011) 1.30
Detection and quantification of myocardial reperfusion hemorrhage using T2*-weighted CMR. JACC Cardiovasc Imaging (2011) 1.27
Beta-catenin downregulation is required for adaptive cardiac remodeling. Circ Res (2007) 1.26
Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents. J Cardiovasc Magn Reson (2014) 1.26
Mutations in GATA4, NKX2.5, CRELD1, and BMP4 are infrequently found in patients with congenital cardiac septal defects. Am J Med Genet A (2008) 1.23
Randomized comparison of reduced fat and reduced carbohydrate hypocaloric diets on intrahepatic fat in overweight and obese human subjects. Hepatology (2011) 1.23
Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet (2011) 1.21
Variability and homogeneity of cardiovascular magnetic resonance myocardial T2-mapping in volunteers compared to patients with edema. J Cardiovasc Magn Reson (2013) 1.21
Public awareness of heart failure in Europe: first results from SHAPE. Eur Heart J (2005) 1.21
Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial. Eur J Heart Fail (2011) 1.20
Advanced methods for quantification of infarct size in mice using three-dimensional high-field late gadolinium enhancement MRI. Am J Physiol Heart Circ Physiol (2009) 1.19
Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension. PLoS One (2008) 1.19
Cardiac hypertrophy in transgenic rats expressing a dominant-negative mutant of the natriuretic peptide receptor B. Proc Natl Acad Sci U S A (2006) 1.18
Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol (2003) 1.17
Refined approach for quantification of in vivo ischemia-reperfusion injury in the mouse heart. Am J Physiol Heart Circ Physiol (2009) 1.17
Beta-Catenin downregulation attenuates ischemic cardiac remodeling through enhanced resident precursor cell differentiation. Proc Natl Acad Sci U S A (2008) 1.17